Metraipolis › archive › dc_0b60fa2c1e92
Structural Enablers of Rare Disease Treatment Coverage in Latin America and the Caribbean: Lessons from Emicizumab — Europe PMC PMID:41892982
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41892982
- DOI
- 10.3390/jmahp14010013
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T07:53:12.205Z
- SHA-256 of the archived text
35b17ae463431c1e6be085fabc583f25c03d122b9eb368abed5ac37b6a01f094- Stable URL of this page
https://metraipolis.com/documento/dc_0b60fa2c1e92
How to cite
Structural Enablers of Rare Disease Treatment Coverage in Latin America and the Caribbean: Lessons from Emicizumab — Europe PMC PMID:41892982 — Europe PMC (en), https://europepmc.org/article/MED/41892982 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0b60fa2c1e92 (Metraipolis archive dc_0b60fa2c1e92, sha256 35b17ae463431c1e6be085fabc583f25c03d122b9eb368abed5ac37b6a01f094)
BibTeX
@misc{dc0b60fa2c1e92,
title = {Structural Enablers of Rare Disease Treatment Coverage in Latin America and the Caribbean: Lessons from Emicizumab — Europe PMC PMID:41892982},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41892982},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0b60fa2c1e92; sha256 35b17ae463431c1e6be085fabc583f25c03d122b9eb368abed5ac37b6a01f094},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41892982. Agents can read the archived copy with the MCP tool read_document.